0001562180-24-004651.txt : 20240604
0001562180-24-004651.hdr.sgml : 20240604
20240604164104
ACCESSION NUMBER: 0001562180-24-004651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240531
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Allan M.
CENTRAL INDEX KEY: 0001652936
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37553
FILM NUMBER: 241018835
MAIL ADDRESS:
STREET 1: C/O REGENXBIO INC.
STREET 2: 9804 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENXBIO Inc.
CENTRAL INDEX KEY: 0001590877
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 471851754
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9804 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-552-8181
MAIL ADDRESS:
STREET 1: 9804 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: REGENXBIO, Inc.
DATE OF NAME CHANGE: 20150116
FORMER COMPANY:
FORMER CONFORMED NAME: ReGenX Biosciences, LLC
DATE OF NAME CHANGE: 20131101
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-05-31
false
0001590877
REGENXBIO Inc.
RGNX
0001652936
Fox Allan M.
C/O REGENXBIO INC.
9804 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
true
false
false
false
false
Common Stock
2024-05-31
4
A
false
4790.00
0.00
A
11286.00
D
Common Stock
722485.00
I
By AMF Family Gift Trust LLC
Common Stock
315000.00
I
By AMF Gift Trust LLC
Common Stock
315000.00
I
By HBF Gift Trust LLC
Common Stock
1529981.00
I
By Quaker Gray LLC
Stock Options (Right to Buy)
14.35
2024-05-31
4
A
false
24454.00
0.00
A
2034-05-31
Common Stock
24454.00
24454.00
D
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the
recipient to the Issuer.
The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an
admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.
/s/ Patrick J. Christmas as attorney-in-fact
2024-06-04